Bell’s Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine
Emergency Medicine
[키워드] administration
Bell’s palsy
bell’s palsy
Brain
Case report
Coronavirus disease 2019
COVID-19
Diagnosis
discharged home
Emergency use authorization
Facial nerve
FDA
Follow-up
healthy
hour
incidence
interferon
interferons
MRI
mRNA COVID-19 vaccine
mRNA vaccine
mRNA vaccines
mRNA-1273
mRNA-1273 vaccine
offered
palsy
pandemic
Patient
Population
potential mechanism
randomized trial
receiving
risk factor
SARS-CoV-2
second dose
Side effect
statistically
stroke
Surveillance
Symptom
the placebo group
the vaccine
Type
Vaccine
Vaccines
weakness
[DOI] 10.7759/cureus.15935 PMC 바로가기 [Article Type] Emergency Medicine
[DOI] 10.7759/cureus.15935 PMC 바로가기 [Article Type] Emergency Medicine